Literature DB >> 18299564

Epitope discovery in West Nile virus infection: Identification and immune recognition of viral epitopes.

Curtis P McMurtrey1, Alina Lelic, Paolo Piazza, Ayan K Chakrabarti, Eric J Yablonsky, Angela Wahl, Wilfried Bardet, Annette Eckerd, Robert L Cook, Rachael Hess, Rico Buchli, Mark Loeb, Charles R Rinaldo, Jonathan Bramson, William H Hildebrand.   

Abstract

Cytotoxic T lymphocytes (CTL) play an important role in the control and elimination of infection by West Nile virus (WNV), yet the class I human leukocyte antigen (HLA)-presented peptide epitopes that enable CTL recognition of WNV-infected cells remain uncharacterized. The goals of this work were first to discover the peptide epitopes that distinguish the class I HLA of WNV-infected cells and then to test the T cell reactivity of newly discovered WNV epitopes. To discover WNV-immune epitopes, class I HLA was harvested from WNV (NY99 strain)-infected and uninfected HeLa cells. Then peptide epitopes were eluted from affinity-purified HLA, and peptide epitopes from infected and uninfected cells were comparatively mapped by mass spectroscopy. Six virus-derived peptides from five different viral proteins (E, NS2b, NS3, NS4b, and NS5) were discovered as unique to HLA-A*0201 of infected cells, demonstrating that the peptides sampled by class I HLA are distributed widely throughout the WNV proteome. When tested with CTL from infected individuals, one dominant WNV target was apparent, two epitopes were subdominant, and three demonstrated little CTL reactivity. Finally, a sequence comparison of these epitopes with the hundreds of viral isolates shows that HLA-A*0201 presents epitopes derived from conserved regions of the virus. Detection and recovery from WNV infection are therefore functions of the ability of class I HLA molecules to reveal conserved WNV epitopes to an intact cellular immune system that subsequently recognizes infected cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18299564      PMCID: PMC2268571          DOI: 10.1073/pnas.0711874105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Experimental infection of horses with West Nile virus and their potential to infect mosquitoes and serve as amplifying hosts.

Authors:  M L Bunning; R A Bowen; B Cropp; K Sullivan; B Davis; N Komar; M Godsey; D Baker; D Hettler; D Holmes; C J Mitchell
Journal:  Ann N Y Acad Sci       Date:  2001-12       Impact factor: 5.691

2.  HLA-B15 peptide ligands are preferentially anchored at their C termini.

Authors:  K R Prilliman; K W Jackson; M Lindsey; J Wang; D Crawford; W H Hildebrand
Journal:  J Immunol       Date:  1999-06-15       Impact factor: 5.422

Review 3.  Pathogenesis of West Nile Virus infection: a balance between virulence, innate and adaptive immunity, and viral evasion.

Authors:  Melanie A Samuel; Michael S Diamond
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

4.  A fluorescent in situ hybridization method in flow cytometry to detect HIV-1 specific RNA.

Authors:  R M Borzì; A Piacentini; M C Monaco; G Lisignoli; A Degrassi; L Cattini; S Santi; A Facchini
Journal:  J Immunol Methods       Date:  1996-06-21       Impact factor: 2.303

Review 5.  Direct class I HLA antigen discovery to distinguish virus-infected and cancerous cells.

Authors:  Angela Wahl; Jon Weidanz; William Hildebrand
Journal:  Expert Rev Proteomics       Date:  2006-12       Impact factor: 3.940

6.  CD8+ T cells require perforin to clear West Nile virus from infected neurons.

Authors:  Bimmi Shrestha; Melanie A Samuel; Michael S Diamond
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

7.  CD8(+) T cell-mediated immune responses in West Nile virus (Sarafend strain) encephalitis are independent of gamma interferon.

Authors:  Yang Wang; Mario Lobigs; Eva Lee; Aulikki Koskinen; Arno Müllbacher
Journal:  J Gen Virol       Date:  2006-12       Impact factor: 3.891

8.  B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus.

Authors:  Michael S Diamond; Bimmi Shrestha; Anantha Marri; Darby Mahan; Michael Engle
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

9.  Simultaneous assessment of cytotoxic T lymphocyte responses against multiple viral infections by combined usage of optimal epitope matrices, anti- CD3 mAb T-cell expansion and "RecycleSpot"

Authors:  Florian K Bihl; Elisabetta Loggi; John V Chisholm; Hannah S Hewitt; Leah M Henry; Caitlyn Linde; Todd J Suscovich; Johnson T Wong; Nicole Frahm; Pietro Andreone; Christian Brander
Journal:  J Transl Med       Date:  2005-05-11       Impact factor: 5.531

10.  The immune epitope database and analysis resource: from vision to blueprint.

Authors:  Bjoern Peters; John Sidney; Phil Bourne; Huynh-Hoa Bui; Soeren Buus; Grace Doh; Ward Fleri; Mitch Kronenberg; Ralph Kubo; Ole Lund; David Nemazee; Julia V Ponomarenko; Muthu Sathiamurthy; Stephen Schoenberger; Scott Stewart; Pamela Surko; Scott Way; Steve Wilson; Alessandro Sette
Journal:  PLoS Biol       Date:  2005-03       Impact factor: 8.029

View more
  32 in total

1.  Cancer immunotherapy. A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells.

Authors:  Beatriz M Carreno; Vincent Magrini; Michelle Becker-Hapak; Saghar Kaabinejadian; Jasreet Hundal; Allegra A Petti; Amy Ly; Wen-Rong Lie; William H Hildebrand; Elaine R Mardis; Gerald P Linette
Journal:  Science       Date:  2015-04-02       Impact factor: 47.728

2.  Demographic and clinical factors associated with persistent symptoms after West Nile virus infection.

Authors:  Robert L Cook; Xiaohui Xu; Eric J Yablonsky; Nikole Sakata; Jennifer H Tripp; Rachel Hess; Paolo Piazza; Charles R Rinaldo
Journal:  Am J Trop Med Hyg       Date:  2010-11       Impact factor: 2.345

3.  Novel HLA-A2-restricted human metapneumovirus epitopes reduce viral titers in mice and are recognized by human T cells.

Authors:  Andrew K Hastings; Pavlo Gilchuk; Sebastian Joyce; John V Williams
Journal:  Vaccine       Date:  2016-04-19       Impact factor: 3.641

Review 4.  Virulence determinants of West Nile virus: how can these be used for vaccine design?

Authors:  Jaclyn A Kaiser; Tian Wang; Alan Dt Barrett
Journal:  Future Virol       Date:  2017-04-28       Impact factor: 1.831

5.  Single-chain HLA-A2 MHC trimers that incorporate an immundominant peptide elicit protective T cell immunity against lethal West Nile virus infection.

Authors:  Sojung Kim; Lijin Li; Curtis P McMurtrey; William H Hildebrand; Jon A Weidanz; William E Gillanders; Michael S Diamond; Ted H Hansen
Journal:  J Immunol       Date:  2010-03-08       Impact factor: 5.422

6.  Toxoplasma gondii activates hypoxia-inducible factor (HIF) by stabilizing the HIF-1alpha subunit via type I activin-like receptor kinase receptor signaling.

Authors:  Mandi Wiley; Kristin R Sweeney; Denise A Chan; Kevin M Brown; Curtis McMurtrey; Eric W Howard; Amato J Giaccia; Ira J Blader
Journal:  J Biol Chem       Date:  2010-06-25       Impact factor: 5.157

7.  Of Mice and Men: Protective and Pathogenic Immune Responses to West Nile virus Infection.

Authors:  Derek Trobaugh; Sharone Green
Journal:  Curr Trop Med Rep       Date:  2015-03-01

8.  A hydrogen peroxide-inactivated virus vaccine elicits humoral and cellular immunity and protects against lethal West Nile virus infection in aged mice.

Authors:  Amelia K Pinto; Justin M Richner; Elizabeth A Poore; Pradnya P Patil; Ian J Amanna; Mark K Slifka; Michael S Diamond
Journal:  J Virol       Date:  2012-12-05       Impact factor: 5.103

9.  Analysis of Major Histocompatibility Complex-Bound HIV Peptides Identified from Various Cell Types Reveals Common Nested Peptides and Novel T Cell Responses.

Authors:  Marijana Rucevic; Georgio Kourjian; Julie Boucau; Renata Blatnik; Wilfredo Garcia Bertran; Matthew J Berberich; Bruce D Walker; Angelika B Riemer; Sylvie Le Gall
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

10.  Immunodominant West Nile Virus T Cell Epitopes Are Fewer in Number and Fashionably Late.

Authors:  Saghar Kaabinejadian; Curtis P McMurtrey; Sojung Kim; Rinki Jain; Wilfried Bardet; Fredda B Schafer; Jason L Davenport; Aaron D Martin; Michael S Diamond; Jon A Weidanz; Ted H Hansen; William H Hildebrand
Journal:  J Immunol       Date:  2016-04-20       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.